Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C hi and Ly6C lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Circulation Année : 2008

Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C hi and Ly6C lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice

Dates et versions

hal-02998813 , version 1 (10-11-2020)

Identifiants

Citer

Christophe Combadiere, Stéphane Potteaux, Mathieu P Rodero, Tabassome Simon, Adeline Pézard, et al.. Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C hi and Ly6C lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice. Circulation, 2008, 117 (13), pp.1649-1657. ⟨10.1161/CIRCULATIONAHA.107.745091⟩. ⟨hal-02998813⟩
22 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More